ibuprofen has been researched along with Idiopathic Parkinson Disease in 13 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess associations between Parkinson disease (PD) and putatively protective factors-smoking, caffeine (coffee, tea, and soft drinks), and nonsteroidal anti-inflammatory drugs (aspirin, ibuprofen, and naproxen)." | 7.74 | Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. ( Hancock, DB; Jewett, R; Martin, ER; Scott, BL; Scott, WK; Stacy, MA; Stajich, JM; Vance, JM, 2007) |
| " There was a dose-response relationship between tablets of ibuprofen taken per week and PD risk (p trend = 0." | 6.47 | Use of ibuprofen and risk of Parkinson disease. ( Ascherio, A; Chen, H; Gao, X; Schwarzschild, MA, 2011) |
| "The present study is to investigate the neuroprotective effect of ibuprofen by intranasal administration of mucoadhesive microemulsion (MMEI) against inflammation-mediated by dopaminergic neurodegeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson's disease (PD)." | 3.83 | Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model. ( Chuttani, K; Mandal, S; Mandal, SD; Sawant, KK; Subudhi, BB, 2016) |
| " After adjusting for the use of ibuprofen and other PD risk factors, subjects with preceding pain symptoms had a higher incidence of PD than those without pain at baseline, and the hazard ratio was 1." | 3.79 | Preceding pain symptoms and Parkinson's disease: a nationwide population-based cohort study. ( Chang, HY; Chiang, YT; Lin, CH; Lin, HH; Wu, RM, 2013) |
| "To assess associations between Parkinson disease (PD) and putatively protective factors-smoking, caffeine (coffee, tea, and soft drinks), and nonsteroidal anti-inflammatory drugs (aspirin, ibuprofen, and naproxen)." | 3.74 | Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. ( Hancock, DB; Jewett, R; Martin, ER; Scott, BL; Scott, WK; Stacy, MA; Stajich, JM; Vance, JM, 2007) |
| " There was a dose-response relationship between tablets of ibuprofen taken per week and PD risk (p trend = 0." | 2.47 | Use of ibuprofen and risk of Parkinson disease. ( Ascherio, A; Chen, H; Gao, X; Schwarzschild, MA, 2011) |
| "Ibuprofen in isolation was examined in four studies and was associated with a 27% reduction in risk (effect estimate 0." | 2.47 | Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. ( Ben-Shlomo, Y; Breen, K; Clarke, CE; Ives, N; Patel, S; Rees, K; Stowe, R, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Kuhlman, G | 1 |
| Auinger, P | 1 |
| Duff-Canning, S | 1 |
| Lang, A | 1 |
| Tanner, C | 1 |
| Marras, C | 1 |
| Singh, A | 1 |
| Tripathi, P | 1 |
| Singh, S | 1 |
| Lin, CH | 1 |
| Wu, RM | 1 |
| Chang, HY | 1 |
| Chiang, YT | 1 |
| Lin, HH | 1 |
| Mandal, S | 1 |
| Mandal, SD | 1 |
| Chuttani, K | 1 |
| Sawant, KK | 1 |
| Subudhi, BB | 1 |
| Samii, A | 1 |
| Etminan, M | 1 |
| Wiens, MO | 1 |
| Jafari, S | 1 |
| Gao, X | 2 |
| Chen, H | 2 |
| Schwarzschild, MA | 3 |
| Ascherio, A | 3 |
| Rees, K | 1 |
| Stowe, R | 1 |
| Patel, S | 1 |
| Ives, N | 1 |
| Breen, K | 1 |
| Clarke, CE | 1 |
| Ben-Shlomo, Y | 1 |
| He, B | 1 |
| Tang, J | 1 |
| Ding, Y | 1 |
| Wang, H | 1 |
| Sun, Y | 1 |
| Shin, JH | 1 |
| Chen, B | 1 |
| Moorthy, G | 1 |
| Qiu, J | 1 |
| Desai, P | 1 |
| Wild, DJ | 1 |
| Simon, KC | 1 |
| Jacobs, E | 1 |
| McCullough, ML | 1 |
| Calle, EE | 1 |
| Thun, MJ | 1 |
| Ton, TG | 1 |
| Heckbert, SR | 1 |
| Longstreth, WT | 1 |
| Rossing, MA | 1 |
| Kukull, WA | 1 |
| Franklin, GM | 1 |
| Swanson, PD | 1 |
| Smith-Weller, T | 1 |
| Checkoway, H | 1 |
| Hancock, DB | 1 |
| Martin, ER | 1 |
| Stajich, JM | 1 |
| Jewett, R | 1 |
| Stacy, MA | 1 |
| Scott, BL | 1 |
| Vance, JM | 1 |
| Scott, WK | 1 |
| Casper, D | 1 |
| Yaparpalvi, U | 1 |
| Rempel, N | 1 |
| Werner, P | 1 |
4 reviews available for ibuprofen and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Humans; Ibuprofen; Inflammation; Neu | 2021 |
NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Cohort Studies; Confid | 2009 |
Use of ibuprofen and risk of Parkinson disease.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antipyretics; Confidence Interv | 2011 |
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Ibuprofen; Neuroprotective Agents; Parkins | 2011 |
9 other studies available for ibuprofen and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Non-steroidal anti-inflammatory drug use and markers of Parkinson's disease progression: A retrospective cohort study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Humans; Ibuprofen; Parkinson Disease; | 2023 |
Preceding pain symptoms and Parkinson's disease: a nationwide population-based cohort study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Data Collection; Female; Human | 2013 |
Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adhesives; Administration, Intranasal; Animals; Corpus | 2016 |
Mining relational paths in integrated biomedical data.
Topics: Algorithms; Computers; Data Collection; Data Mining; Databases, Factual; Humans; Hypoglycemic Agents | 2011 |
Prospective study of statin use and risk of Parkinson disease.
Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Female; Follow-Up Studi | 2012 |
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease.
Topics: Acetaminophen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Female; Human | 2005 |
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studi | 2006 |
Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Beverages; Caffeine; Case-Control Studies; F | 2007 |
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
Topics: Acetaminophen; Animals; Aspirin; Cell Count; Cells, Cultured; Dopamine; Fetus; Glutamic Acid; Ibupro | 2000 |